Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  van der Velden, Walter J F M ^a   Herbers, Alexandra H E ^a   Feuth, Ton ^a   Schaap, Nicolaas P M ^a   Peter Donnelly, J ^a   Blijlevens, Nicole M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARMUSTINE; CIPROFLOXACIN; CITRULLINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MELPHALAN; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LUNG INJURY; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; AXILLA TEMPERATURE; BACTEREMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; INTESTINE INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; NEUTROPENIA; NEUTROPHIL COUNT; NONMYELOABLATIVE CONDITIONING; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; WHOLE BODY RADIATION; ADOLESCENT; BIOSYNTHESIS; CONGENITAL MALFORMATION; CYTOLOGY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; LUNG DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; MUCOSA; NEUTROPHIL; PATHOLOGY; PROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; BACTEREMIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTESTINES; LUNG DISEASES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEUTROPHILS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING;

EID: 78650896797     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015156     Document Type: Article

References (38)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340.
2. From the Immunocompromised Host Society (1990) The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 161: 397- 401.
3. Andersen J, Heilmann C, Jacobsen N, Nielsen C, Bendtzen K, et al. (2006) Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant 37: 635-640.
4. Blijlevens NM, Donnelly JP, DePauw BE (2005) Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 36: 703-707.
5. Schots R, Van Riet I, Othman TB, Trullemans F, De Waele M, et al. (2002) An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant 30: 441-446.
6. Schots R, Kaufman L, Van Riet I, Othman BT, De Waele M, et al. (2003) Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 17: 1150-1156.
7. Fassas AB, Miceli MH, Grazzlutti M, Dong L, Barlogie B, et al. (2005) Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation. Leuk Lymphoma 46: 1159-1161.
8. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, et al. (2000) Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 26: 419-426.
9. Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, et al. (2008) Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood 112: 1539-1542.
10. Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR (2010) Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant. In press.
11. Kim SY, Lee DG, Kim MS, Kim HJ, Lee S, et al. (2008) The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease. Am J Hematol 83: 784-788.
12. Tsuji E, Hiki N, Nomura S, Fukushima R, Kojima J, et al. (2003) Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 107: 303-308.
13. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, et al. (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33: 448-460.
14. Ong ZY, Gibson RJ, Bowen JM, Stringer AM, Darby JM, et al. (2010) Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiat Oncol 5: 22.
15. Donnelly JP, Muus P, Horrevorts AM, Sauerwein RW, de Pauw BE (1993) Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients. Scand J Infect Dis 25: 43-50.
16. Hill GR, Ferrara JL (2000) The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95: 2754-2759.
17. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, et al. (2000) hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. J Immunol 165: 6612-6619.
18. Blijlevens NM, Donnelly JP, de Pauw BE (2005) Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 35: 707-711.
19. Johansson JE, Ekman T (1997) Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings. Bone Marrow Transplant 19: 921-925.
20. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, et al. (2003) Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 124: 1210-1219.
21. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP (2004) Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 34: 193-196.
22. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM (2010) Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol 2010 21: 1706-1711.
23. van der Velden WJFM, Blijlevens NM, Feuth T, Donnelly JP (2009) Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant 43: 55-60.
24. de Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP (1994) Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group. Ann Intern Med 120: 834-844.
25. de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, et al. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813-1821.
26. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, et al. (2000) Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 28: 232-235.
27. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15: 825-828.
28. Gorak E, Geller N, Srinivasan R, Espinoza-Delgado I, Donohue T, et al. (2005) Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. Biol Blood Marrow Transplant 11: 542-550.
29. Bachanova V, Brunstein CG, Burns LJ, Miller JS, Luo X, et al. (2009) Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma. Bone Marrow Transplant 43: 237-244.
30. Herbers AH, Blijlevens NM, Donnelly JP, de Witte TJ (2008) Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplant 42: 345-349.
31. Costa SF, Barone AA, Miceli MH, van der Heijden IM, Soares RE, et al. (2006) Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study. Am J Infect Control 34: 36-40.
32. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST (1998) The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82: 2275-2281.
33. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, et al. (2000) Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 31: 1126-30.
34. Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14: 1201-1207.
35. Guiot HF, Peters WG, van den Broek PJ, van der Meer JW, Kramps JA, et al. (1990) Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 18: 131-137.
36. Chakraverty R, Cote D, Buchli J, Cotter P, Hsu R, et al. (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med 203: 2021-2031.
37. Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, et al. (2008) Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Transplantation 86: 968-976.
38. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, et al. (2004) Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 104: 1550-1558.